July 6 (Reuters) - Kazia Therapeutics Ltd (KZA) :
- KAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA FOR TREATMENT OF SOLID TUMOR BRAIN METASTASES HARBORING PI3K PATHWAY MUTATIONS IN COMBINATION WITH RADIATION THERAPY
- KAZIA THERAPEUTICS LTD - FURTHER DATA FROM ONGOING PHASE 1 STUDY IS EXPECTED IN 1Q CY2024
- Forums
- ASX - By Stock
- News: KZA Kazia's Paxalisib Receives Fast Track Designation From FDA For Treatment Of Solid Tumor...
July 6 (Reuters) - Kazia Therapeutics Ltd (KZA) : KAZIA'S...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online